NUGALVIQ

Serial Number 90430250
606

Registration Progress

Application Filed
Dec 30, 2020
Under Examination
Oct 5, 2021
Approved for Publication
Aug 10, 2021
Published for Opposition
Aug 10, 2021
Registered

Trademark Image

NUGALVIQ

Basic Information

Serial Number
90430250
Filing Date
December 30, 2020
Published for Opposition
August 10, 2021
Abandonment Date
November 11, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 11, 2024
Classes
005

Rights Holder

Applied Therapeutics, Inc.

03
Address
545 Fifth Avenue, Suite 1400
New York, NY 10017

Ownership History

Applied Therapeutics, Inc.

Original Applicant
03
New York, NY

Applied Therapeutics, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Anna Kurian Shaw

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

42 events
Date Code Type Description Documents
Nov 11, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 11, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Mar 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 22, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 22, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 19, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 19, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 14, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 10, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 10, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 12, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 12, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 12, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 9, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 7, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 7, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 7, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 6, 2022 NOAC E CORRECTED NOA E-MAILED Loading...
May 5, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 5, 2022 ICNA I NOTICE OF ALLOWANCE CORRECTION ENTERED Loading...
Apr 5, 2022 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Mar 24, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 22, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 22, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 22, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 5, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 10, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 10, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 21, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 2, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 1, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 31, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 31, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 31, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 31, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 31, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 2, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)

Classification

International Classes
005